SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $625 | -100.0% | 27,022 | -68.0% | 0.01% | -81.2% |
Q3 2022 | $2,413,000 | +264.0% | 84,573 | +214.2% | 0.03% | +300.0% |
Q2 2022 | $663,000 | +151.1% | 26,921 | +640.8% | 0.01% | +166.7% |
Q4 2020 | $264,000 | -23.9% | 3,634 | -56.0% | 0.00% | -66.7% |
Q2 2020 | $347,000 | -58.5% | 8,267 | -73.3% | 0.01% | -80.4% |
Q1 2020 | $837,000 | – | 30,996 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 4,831,307 | $125,662 | 14.04% |
Finepoint Capital LP | 643,000 | $16,724 | 5.41% |
Boxer Capital, LLC | 3,421,541 | $88,994,281 | 4.69% |
Deep Track Capital, LP | 3,109,886 | $80,888,135 | 3.40% |
Artal Group S.A. | 2,000,000 | $52,020 | 2.90% |
EcoR1 Capital, LLC | 3,460,208 | $90,000,010 | 2.74% |
M28 Capital Management LP | 109,900 | $2,858,499 | 2.72% |
Orbimed Advisors | 5,250,000 | $136,552,500 | 2.61% |
Perceptive Advisors | 2,617,691 | $68,086,143 | 1.91% |
SPHERA FUNDS MANAGEMENT LTD. | 316,625 | $8,235,416 | 1.77% |